ACHN-975 is a First-in-class and Selective LpxC Inhibitor
The bacterial enzyme UDP-3-O--N-acetylglucosamine deacetylase (LpxC) catalyzes the first committed step of lipid A biosynthesis. Additionally, the process represents a promising target in the development of novel antibiotics against Gram-negative…